2024
|
Invention
|
Urea compounds, compositions, and methods for treating asthma and parkinson's disease. Disclosed ... |
|
Invention
|
Compounds targeting kras g12d mutations and their uses. The present disclosure relates to compoun... |
2021
|
Invention
|
Method for screening plk-1 inhibitor, inhibitor screened thereby, and use thereof. The present in... |
|
Invention
|
Methods and compositions for treatment of asthma or parkinson's disease.
The present invention r... |
2020
|
Invention
|
Calixcrowns and uses thereof. Provided herein are novel calixcrowns, such as those of Formula (I)... |
|
Invention
|
Calixcrowns and uses thereof.
Provided herein are novel calixcrowns, such as those of Formula I,... |
|
Invention
|
Methods and compositions for treatment of lung cancer. The present invention relates to methods a... |
2019
|
Invention
|
Methods and compositions for treatment of asthma or parkinson's disease. The present invention re... |
2016
|
Invention
|
Composition for treatment of inflammatory bowel disease and atopic dermatitis. The present invent... |
2011
|
Invention
|
Method for screening osteopontin inhibitor and inhibitor obtained from the method.
Provided is a... |
|
Invention
|
Inhibitor for dipeptidyl peptidase iv. The present invention relates to a substance for detecting... |
2010
|
Invention
|
Method for screening inhibitor for inhibiting interaction between beta-amyloid peptide and vegf a... |
|
Invention
|
Method for screening for substance which inhibits interaction between beta amyloid peptide and ve... |
2009
|
Invention
|
Method for screening osteopontin inhibitor and inhibitor prepared thereby. The present invention ... |